BACKGROUND: The objective of this study was to assess the cost effectiveness of ICD-CRT
versus ICD alone in patients with left ventricular dysfunction and a wide QRS complex. In a …

Objective: Clinical evidence supports the use of cardiac resynchronization therapy (CRT) in
advanced heart failure, but its cost-effectiveness is still unclear. This analysis assessed the …

Objective To determine the incremental value of implantable cardioverter defibrillators (ICD)
in contemporary optimally treated patients with heart failure (HF) undergoing cardiac …

Aims There are limited and contradictory data on the effects of CRT with implantable
cardioverter defibrillator (CRT‐D) on mortality as compared with CRT with pacemaker (CRT …

Background Current guidelines did not provide recommendations on indications of an
additional implantable cardioverter‐defibrillator (ICD) to patients receiving cardiac …

Cardiac resynchronization therapy (CRT) is a highly efficient treatment modality for patients
with severe congestive heart failure and intraventricular dyssynchrony. However, the high …

Aims Cardiac resynchronization therapy (CRT) for chronic heart failure with left ventricular
systolic dysfunction (LVSD) consistently improves survival against optimal medical therapy …

NICE and the AHA were the only guidelines to recommend or consider CRT in NYHA class I
patients. NICE's recommendation was based on the manufacturer-sponsored CEA, 2, 6 …

Abstract Aims The SMART (Strategic MAnagement to optimize response to cardiac
Resynchronization Therapy) Registry was designed to assess real‐world outcomes for …

BACKGROUND This assessment updates and expands on two previous technology
assessments that evaluated implantable cardioverter defibrillators (ICDs) for arrhythmias …